Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurokinin receptors, also known as tachykinin receptors, are a family of three G protein-coupled receptors (NK1, NK2, and NK3) that mediate the biological effects of tachykinin neuropeptides such as Substance P, Neurokinin A, and Neurokinin B. These receptors are widely distributed throughout the central and peripheral nervous systems, where they play critical roles in pain transmission, inflammation, smooth muscle contraction, and the regulation of the hypothalamic-pituitary-gonadal axis. NK1 receptors are primarily involved in the emetic reflex and pain perception, making them key targets for antiemetic drugs like aprepitant used in chemotherapy-induced nausea and vomiting. NK2 receptors are predominantly found in the respiratory and gastrointestinal tracts, influencing smooth muscle tone and airway hyperresponsiveness. NK3 receptors have gained significant clinical attention for their role in regulating gonadotropin-releasing hormone (GnRH) secretion, leading to the development of antagonists like fezolinetant for treating menopausal vasomotor symptoms. Therapeutic intervention typically involves small-molecule antagonists designed to block the binding of endogenous ligands, thereby alleviating symptoms associated with overactive tachykinin signaling.
Competitive antagonism of tachykinin neuropeptides (Substance P, Neurokinin A, and Neurokinin B) at their respective G protein-coupled receptors, inhibiting downstream signaling pathways involved in emesis, pain, and endocrine regulation.
8 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurokinin receptor (NK receptor).